Giant prolactinomas in adolescence: An uncommon cause of blindness

Child's Nervous System

Volumn 23, Issue 2, 2007, Pages 213-217

  Semple, Patrick ^a   Fieggen, Graham ^a   Parkes, Jeannette ^a   Levitt, Naomi ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Adolescence; Blindness; Childhood; Prolactinoma

Indexed keywords

BROMOCRIPTINE; HYDROCORTISONE; PROLACTIN; THYROXINE;

ADOLESCENT; ARTICLE; BLINDNESS; CANCER INVASION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE ATROPHY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; SELLA TURCICA; SKULL BASE; TUMOR VOLUME; VISUAL SYSTEM EXAMINATION;

ADOLESCENT; BLINDNESS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY NEOPLASMS; PROLACTINOMA;

EID: 33846084660     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-006-0177-5     Document Type: Article

References (35)

1. Guler E, Kutluk T, Akalan N, Akyuz C, Atahan L, Buyukpumukcu M (2003) Acute blindness as a presenting sign in childhood non-Hodgkin lymphoma. J Pediatr Hematol Oncol 25(1):69-72
2. Kolliass SS, Barkovich AJ, Edwards MS (1991-1992) Magnetic resonance analysis of suprasellar tumors of childhood. Pediatr Neurosurg 17(6):284-303
3. Abe T, Ludecke DK (2002) Transnasal surgery for prolactin-secreting pituitary adenomas in childhood and adolescence. Surg Neurol 57(6):378-379
4. Chang CZ, Wang CJ, Howng SL (1999) Pituitary adenomas in adolescence - ten-year experience and literature review. Kaohsiung J Med Sci 15(12):691-696
5. Maira G, Anile C (1990) Pituitary adenomas in childhood and adolescence. Can J Neurol Sci 17(1):83-87
6. De Menis E, Visentin A, Billeci D, Tramontin P, Agostini S, Marton E, Conte N (2001) Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases. J Endocrinol Investig 24(2):92-97
7. Minniti G, Jaffrain-Rea ML, Ferretti E, Gulino A, Tamburrano G (1996) Macroprolactinomas as cause of delayed puberty. A report of two cases and effects of medical therapy. Minerva Endocrinol 21(2):67-71
8. Duntas LH (2001) Prolactinomas in children and adolescents - consequences in adult life. J Pediatr Endocrinol Metab 14:1227-1232
9. Maier W, Laubert A, Weinel P (1994) Acute bilateral blindness in childhood caused by rhabdomyosarcomas and malignant lymphoma. J Laryngol Otol 108(10):873-877
10. Cook RJ, Uttley D, Wilkens PR, Archer DJ, Bell BA (1994) Prolactinomas in men masquerading as invasive skull base tumours. Br J Neurosurg 8(1):51-55
11. Poissant TY, Barnes PD, Anthony DC, Spack N, Scott RM, Tarbell NJ (1996) Hemorrhagic pituitary adenomas of adolescence. AJNR Am J Neuroradiol 17(10):1907-1912
12. Ramelli GP, von der Weid N, Stanga Z, Mullis PE, Buergi U (1998) Suprasellar germinomas in childhood and adolescence: Diagnostic pitfalls. J Pediatr Endocrinol Metab 11(6):693-697
13. Dyer EH, Civit T, Visot A, Delalande O, Derome P (1994) Transsphenoidal surgery for pituitary adenomas in children. Neurosurgery 34(2):207-212
14. Kashiwagi S, Nishikazi T, Harada K, Ito H, Setoguchi M, Takahashi M, Ishihara T (1998) Prolactin-secreting macroadenoma in a prepubertal girl. Childs Nerv Syst 14(10):602-605
15. Mindermann T, Wilson CB (1995) Pediatric pituitary adenoma. Neurosurgery 36(2):259-268
16. Haddad SF, VanGilder JC, Menezes AH (1991) Pediatric pituitary tumors. Neurosurgery 29(4):509-514
17. Fideleff HL, Boquete HR, Sequera A, Suarez M, Sobrado P, Giaccio A (2000) Peripheral prolactinomas: Clinical presentation and long term outcome with different therapeutic approaches. J Pediatr Endocrinol Metab 13(3):261-267
18. Delgrange E, Troillas J, Maiter D, Donckier J, Tourniaire J (1997) Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study. J Clin Endocrinol Metab 82(7):2102-2107
19. Nishioka H, Haraoka J, Akada K (2003) Growth potential of prolactinomas in men: Is it really different from women? Surg Neurol 59(5):386-390
20. Kane LA, Leinung MC, Scheithauer BW, Bergstralh EJ, Laws ER Jr, Groover RV, Kovacs K, Horvath E, Zimmerman D (1994) Pituitary adenomas in childhood and adolescence. J Clin Endocrinol Metab 79(4):1135-1140
21. Coloa A, Loche S, Cappa M, Di Sarno A, Landi ML, Sanacchiaro FS, Faccioli L, Lombardi G (1998) Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. J Clin Endocrinol Metab 83(8):2777-2780
22. Dissaneevate P, Warne GL (1998) Hyperprolactinaemia and pituitary adenomas in adolescence. J Pediatr Endocrinol Metab 11(4):531-541
23. Ross RJ, McEniery JM, Grossman A, Doniach I, Besser GM, Savage MO (1989) Massive prolactinoma with galactorrhoea in a prepubertal boy. Postgrad Med J 65(764):403-406
24. Canavo S, Venturino M, Curto L, De Menis E, D'Arrigo C, Tita P, Billeci D, Trimarchi F (2003) Clinical presentation and outcome of pituitary adenomas in teenagers. Clin Endocrinol 58(4):519-527
25. Howlett TA, Wass JA, Grossman A, Plownan PN, Charlesworth M, Touzel R, Rees LH, Savage MO, Besser GM (1989) Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: Response to medical therapy. Clin Endocrinol (Oxf) 30(2):131-140
26. Partington MD, Davis DH, Laws ER Jr, Scheithauer BW (1994) Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery. J Neurosurg 80(2):209-216
27. Berezin M, Shimon I, Hadani M (1995) Prolactinomas in 53 men: Clinical characteristics and modes of treatment (male prolactinoma). J Endocrinol Investig 18(6):436-441
28. Krassas GE, Pontikides N, Kaltsas T (1999) Giant prolactinomas presented as unilateral exopthalmos in a prepubertal boy: Response to cabergoline. Horm Res 52(1):45-48
29. Calao A, Di Sarno A, Landi ML, Cirillo S, Sarnacchiaro F, Facciolli G, Pivonello R, Cataldi M, Merola B, Annunziato L, Lombardi G (1997) Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 82(11):3574-3579
30. Caloa A, Vitale G, Cappabianca P, Briganti F, Ciccarelli A, De Rosa M, Zarrilli S, Lombardi G (2004) Outcome of cabergoline treatment in men with prolactinoma: Effects of a 24 month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab 89(4):1704-1711
31. Corsello SM, Ubertini G, Altomare M, Lovicu RM, Migneco MG, Colosimo C (2003) Giant prolactinomas in men: Efficacy of cabergoline treatment. Clin Endocrinol (Oxf) 58(5):662-670
32. Orrego JJ, Chandler WF, Barkan AL (2000) Pergolide as primary therapy for macroprolactinomas. Pituitary 3(4):251-256
33. Pontikedes N, Krassas GE, Nikopoulou E, Kaltsas T (2000) Cabergoline as a first-line treatment in newly diagnosed macroprolactinomas. Pituitary 2(4):277-281
34. Scholtz PN, Ginsberg L, McCutcheon IE, Samaan N, Leavens M, Gagel RF (2000) Quinagolide in the management of prolactinoma. Pituitary 3(4):239-349
35. Tyson D, Reggiardo D, Sklar C, David R (1993) Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy. Am J Dis Child 147(10):1057-1061